Overview

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

Summary

For people with HIV who are currently taking specific medications (including Sustiva (efavirenz)) and have no detectable viral load, this study tracks how patients do if they take their medications for five days of the week compared with seven days of the week.

Phase:

Phase 4

Details

Lead Sponsor:

Community Research Initiative of New England

Collaborator:

The Campbell Foundation

Treatments:

Efavirenz
Emtricitabine
Tenofovir